Surveillance recommendations for DICER1 pathogenic variant carriers: a report from the SIOPE Host Genome Working Group and CanGene-CanVar Clinical Guideline Working Group
Jette J. Bakhuizen(Heidelberg University), Stephanie E. Smetsers(Princess Máxima Center), Johannes H. M. Merks, Roula Farah, Beate B. Dörgeloh, Helen Hanson(University of Exeter), A. Kulkarni(Guy's and St Thomas' NHS Foundation Trust), Rosalyn Jewell, Marjolijn C.J. Jongmans(Utrecht University), Michaela Kuhlen, K. Katsibardi, Julian Adlard(Chapel Allerton Hospital), Tim Ripperger, Anna Poluha, Juliane Hoyer, Karin van der Tuin(Leiden University), Emma R. Woodward(Royal Manchester Children's Hospital), Nicolas Waespe, Stavros Glentis, Hanneke M. van Santen(University Medical Center Utrecht), Annemieke S. Littooij, Marc Tischkowitz(University of Cambridge), Anna Kelsey, Thomas Semple, Bernadette Brennan(Royal Manchester Children's Hospital), Fiona Lalloo(St Mary's Hospital), Karolina Nemes, Kirsi Jahnukainen(University of Helsinki), Alex Murray(University Medical Center Utrecht), Karin Wadt(Copenhagen University Hospital), Rachel S. van Leeuwaarde(Utrecht University), Andrea Meinhardt, D. Gareth Evans(Manchester Academic Health Science Centre), Munaza Ahmed(Great Ormond Street Hospital), Åse Krogh Rasmussen(Steno Diabetes Centers), Anthony Penn, Tabib Dabir(Belfast Health and Social Care Trust), Axel Karow, Kai Ren Ong(Birmingham Women's Hospital), Lisa Golmard(Université Paris Sciences et Lettres)
Cited by 53
Related Papers
Soft tissue and visceral sarcomas: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up☆
|Annals of Oncology|2021|978
Immune Checkpoint Inhibition for Hypermutant Glioblastoma Multiforme Resulting From Germline Biallelic Mismatch Repair Deficiency
|Journal of Clinical Oncology|2016|867
Comprehensive Analysis of Hypermutation in Human Cancer
|Cell|2017|795